Aldosterone Synthase Inhibition in Hypertension

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386 · see citing works

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · see citing works

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · see citing works

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941 · see citing works

Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · see citing works

Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease

Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O’Donnell, C. J., Kannel, W. B., & Levy, D. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,079 · see citing works

Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons

Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 573 · see citing works

Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.

Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505 · see citing works

Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes

Epstein, M., Williams, G. H., Weinberger, M. H., Lewin, A. J., Krause, S. L., Mukherjee, R., Patni, R., & Beckerman, B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240106 · Cited by 459 · see citing works

The incidence and implications of aldosterone breakthrough

Bomback, A. S., & Klemmer, P. J. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0575 · Cited by 418 · see citing works

Aldosterone and end-organ damage

Brown, N. J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 318 · see citing works

Effects of Aldosterone on the Vasculature

Schiffrin, E. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000201443.63240.a7 · Cited by 299 · see citing works

Aldosterone in the development and progression of renal injury

Hollenberg, N. K. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00701.x · Cited by 272 · see citing works

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

Makani, H., Bangalore, S., Desouza, K. A., Shah, A., & Messerli, F. H. (2013) · BMJ · doi:10.1136/bmj.f360 · Cited by 244 · see citing works

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial

Calhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227 · see citing works

Aldosterone and end-organ damage

Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 224 · see citing works

Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet

Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213 · see citing works

Aldosterone Synthase Inhibition With LCI699

Amar, L., Azizi, M., Ménard, J., Peyrard, S., Watson, C. E., & Plouin, P. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 204 · see citing works

Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism

Nishizaka, M., Zaman, M. A., Green, S. A., Renfroe, K. Y., & Calhoun, D. A. (2004) · Circulation · doi:10.1161/01.cir.0000129307.26791.8e · Cited by 201 · see citing works

Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage

Fiebeler, A., Nussberger, J., Shagdarsuren, E., Rong, S., Hilfenhaus, G., Al‐Saadi, N., Dechend, R., Wellner, M., Meiners, S., Maser‐Gluth, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.521625 · Cited by 182 · see citing works

Association Between Increased Plasma Levels of Aldosterone and Decreased Systemic Arterial Compliance in Subjects With Essential Hypertension

Blacher, J. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00301-4 · Cited by 152 · see citing works

Aldosterone Escape during Angiotensinconverting Enzyme Inhibitor Therapy in Essential Hypertensive Patients with Left Ventricular Hypertrophy

Sato, A., & Saruta, T. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900103 · Cited by 148 · see citing works

Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism

Gaddam, K. K., Corros, C., Pimenta, E., Ahmed, M. I., Denney, T. S., Aban, I., Inusah, S., Gupta, H., Lloyd, S. G., Oparil, S., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.141531 · Cited by 146 · see citing works

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

Lane, D. A., Shah, S., & Beevers, D. G. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328014954d · Cited by 137 · see citing works

Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition

Strushkevich, N. V., Gilep, A. A., Shen, L., Arrowsmith, C. H., Edwards, A. M., Usanov, S. A., & Park, H. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1287 · Cited by 136 · see citing works

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

Mulder, P. G. H., Mellin, V., Favre, J., Vercauteren, M., Rémy‐Jouet, I., Monteil, C., Richard, V. J., Renet, S., Henry, J. P., Jeng, A. Y., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn277 · Cited by 126 · see citing works

Novel therapeutic targets for hypertension

Paulis, L., & Unger, T. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.85 · Cited by 123 · see citing works

Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt

Lea, W. B., Kwak, E. S., Luther, J. M., Fowler, S. M., Wang, Z., Ma, J., Fogo, A. B., & Brown, N. J. (2009) · Kidney International · doi:10.1038/ki.2009.9 · Cited by 115 · see citing works

Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension

El‐Gharbawy, A., NADIG, V., Kotchen, J. M., Grim, C. E., Sagar, K. B., Kaldunski, M. L., Hamet, P., Pausová, Z., Gaudet, D., Gossard, F., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.845 · Cited by 108 · see citing works

Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension

Karns, A. D., Bral, J. M., Hartman, D., Peppard, T., & Schumacher, C. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12051 · Cited by 104 · see citing works

[Summary of the article: Zannad F, McMurray JJV, Krum H et al.; for the EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med, 2011; 364: 11-21].

Rywik, T. M. (2011) · PubMed · Cited by 98 · see citing works

Aldosterone Production and Insulin Resistance in Healthy Adults

Garg, R., Hurwitz, S., Williams, G. H., Hopkins, P. N., & Adler, G. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2521 · Cited by 96 · see citing works

Aldosterone-receptor antagonism in hypertension

Jansen, P. M., Danser, A. J., Imholz, B. P. M., & van den Meiracker, A. H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832810ed · Cited by 91 · see citing works

Hyperaldosteronism and Hypertension

Grim, C. E., Cowley, A. W., Hamet, P., Gaudet, D., Kaldunski, M. L., Kotchen, J. M., Krishnaswami, S., Pausová, Z., Roman, R., Tremblay, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154364.00763.d5 · Cited by 88 · see citing works

The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study

Andersen, K. K., Hartman, D., Peppard, T., Hermann, D. J., Ess, P. J. V., Lefkowitz, M. P., & Trapani, A. J. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00667.x · Cited by 70 · see citing works

High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations

Meneton, P., Galan, P., Bertrais, S., Heudes, D., Herçberg, S., & Ménard, J. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.27 · Cited by 63 · see citing works

Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology

Funder, J. W., & Mihailidou, A. S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.029 · Cited by 58 · see citing works

Programming of Hypertension

Reynolds, R. M., Walker, B. R., Phillips, D. I., Dennison, E. M., Fraser, R., MacKenzie, S. M., Davies, E., & Connell, J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129320 · Cited by 47 · see citing works

Aldosterone antagonist therapy in resistant hypertension

Zannad, F. M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280d9434e · Cited by 46 · see citing works

The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects

Trunet, P., Mueller, P., Girard, F., Aupetit, B., Bhatnagar, A. S., Zognbi, F., Ezzet, F., & Ménard, J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1531483 · Cited by 46 · see citing works

Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis

Hartmann, R. W., Müller, U., & Ehmer, P. B. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00049-7 · Cited by 44 · see citing works

HORMONAL AND ELECTROLYTE RESPONSES TO THE ALDOSTERONE SYNTHASE INHIBITOR LCI699 IN SODIUM DEPLETED HEALTHY SUBJECTS

Ménard, J., Watson, C. E., Rebello, S. S., Zhang, Y. M., & Dole, W. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)60584-0 · Cited by 38 · see citing works

Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome

Mulè, G., Nardi, E., Cusimano, P., Cottone, S., Seddio, G., Geraci, C., Palermo, A., Andronico, G., & Cerasola, G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.225 · Cited by 33 · see citing works

Fadrozole Reverses Cardiac Fibrosis in Spontaneously Hypertensive Heart Failure Rats: Discordant Enantioselectivity Versus Reduction of Plasma Aldosterone

Minnaard‐Huiban, M., Emmen, J. M. A., Roumen, L., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0584 · Cited by 23 · see citing works

Aldosterone synthase inhibitors: pharmacological and clinical aspects.

Jansen, P. M., van den Meiracker, A. H., & Danser, A. J. (2009) · PubMed · Cited by 22 · see citing works

Eplerenone

Brown, R. E., Quirk, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1039 · Cited by 22 · see citing works

The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-β-hydroxylase

Adams, C. M., Hu, C.-W., Jeng, A. Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.086 · Cited by 13 · see citing works

Aldosterone Synthase Inhibition: A Promising Beginning

Hollenberg, N. K. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0185-z · Cited by 2 · see citing works

Obesity, kidney dysfunction and hypertension: mechanistic links

Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654 · see citing works

Pathology and gene mutations of aldosterone-producing lesions

Nishimoto, K., Ogishima, T., Sugiura, Y., Suematsu, M., & Mukai, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej22-0492 · Cited by 8 · see citing works

Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo

Ries, C., Lucas, S., Heim, R., Birk, B., & Hartmann, R. W. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.04.013 · Cited by 23 · see citing works

Effect of progesterone on aldosterone secretion in rats.

Braley, L. M., MENACHERY, A. I., Yao, T. M., et al. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895346 · Cited by 29 · see citing works

Relationship of aldosterone synthase gene polymorphism with plasma aldosterone levels of essential hypertension patients

Hu, X. (2004) · Shiyong yixue zazhi

Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human

Cerny, M. A., Csengery, A., Schmenk, J., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.004 · Cited by 17 · see citing works